CXCL12 rs18011157 polymorphısm in patients wıth non-Hodgkin's lymphoma | Zendy

Gülsüm Emel Pamuk | Zendy; Hilmi Tozkır | Zendy; Mehmet Şevki Uyanık | Zendy; Hakan Gürkan | Zendy; Julide Duymaz | Zendy; Ömer Nurı Pamuk | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CXCL12 rs18011157 polymorphısm in patients wıth non-Hodgkin's lymphoma

Author(s) -

Gülsüm Emel Pamuk,

Hilmi Tozkır,

Mehmet Şevki Uyanık,

Hakan Gürkan,

Julide Duymaz,

Ömer Nurı Pamuk

Publication year - 2017

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.203596

Subject(s) - medicine , gastroenterology , genotype , lymphoma , international prognostic index , univariate analysis , non hodgkin's lymphoma , multivariate analysis , b symptoms , polymorphism (computer science) , lactate dehydrogenase , rituximab , biology , genetics , gene , enzyme , biochemistry

We studied CXCL12-related rs18011157 polymorphism in non-Hodgkin lymphoma (NHL) patients. We also determined the effect of this polymorphism on clinical features and outcome of NHL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research